eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2023
vol. 9
 
Share:
Share:
Original paper

Concomitant diverticulosis among patients undergoing liver transplantation. Does it influence the length of hospitalization after the procedure?

Tomasz Menżyk
1
,
Lubomir Skladany
2, 3
,
Svetlana Adamcova-Selcanova
2
,
Janka Vnencakova
2
,
Daniela Zilincanova
2
,
Natalia Bystrianska
2
,
Dorota Hudy
4
,
Magdalena Skonieczna
5, 6
,
Wojciech Marlicz
7
,
Michał Kukla
8, 9

  1. Department of Internal Medicine, Gastroenterology and Hematology, St. Lucas Hospital, Tarnów, Poland
  2. Department of Internal Medicine and HEGITO (Hepatology, Gastroenterology and Liver Transplantation), F.D. Roosevelt University Hospital, Banska Bystrica, Slovakia
  3. Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia
  4. Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
  5. Department of Systems Biology and Engineering, Silesian University of Technology, Gliwice, Poland
  6. Biotechnology Centre, Silesian University of Technology, Gliwice, Poland
  7. Department of Gastroenterology, Pomeranian Medical University, Szczecin, Poland
  8. Department of Internal Medicine and Geriatrics, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland
  9. Department of Endoscopy, University Hospital, Cracow, Poland
Clin Exp HEPATOL 2023; 9, 4: 344-350
Online publish date: 2023/11/13
Article file
- Concomitant.pdf  [0.11 MB]
Get citation
 
PlumX metrics:
 

Introduction

During the last decades liver transplantation (LT) has been playing an essential role in the therapeutic path of liver diseases. It is mostly a consequence of the lack of alternative therapies and of the good post-transplant survival of approximately 90% and 80% at 1 and 5 years, respectively [1]. Based on the European Association for the Study of the Liver (EASL) Clinical Practice Guidelines for LT [2], there are three types of patients who are entered on the LT waiting list: 1) patients with end-stage liver disease (ESLD), mostly decompensated liver cirrhosis, included in the waiting list on the principle of the “sickest first”, based mainly on the calculation of the Model for End Stage Liver Diseases (MELD) score, 2) patients with the development of hepatocellular carcinoma (HCC) and 3) patients with acute liver failure. The MELD score (calculated from objective measures such as creatinine, bilirubin, and international normalized ratio [INR]) was developed to determine the short-term prognosis for patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) after gastrointestinal bleeding [3], and then proposed for predicting 3-month mortality in patients with ESLD.

Since the results of LT have shown significant improvement, more patients have been eligible for LT, while the indications have been evolving. As a consequence, this procedure starts pertaining to older patients as well as patients with multiple comorbidities, including diverticulosis. Diverticulosis of the colon is one of the most common anatomical colonic alterations, detected during colonoscopy or computed tomography mostly in developed countries. Diverticula of the large bowel are characterized by mucosal/submucosal herniations through outpouching in the muscle layer at anatomical weak points where blood vessels penetrate to supply the mucosa [3]. These types of diverticula occur typically in the left colon. The real prevalence of diverticulosis is unknown, although its age-dependency is proven, and it is mostly detected among patients aged 65 years or more. About 85-90% of patients remain asymptomatic; the rest develop clinically significant and symptomatic diverticulosis, leading to the so-called “diverticular disease” [4]. Despite its frequency, the pathogenesis of diverticulosis is still controversial and considered to be multifactorial. Several risk factors for diverticulosis have been identified, such as older age, constipation, a high intake of red meat, a low-fiber diet, and a low level of physical activity [5].

As mentioned above, the development in the field of solid organ transplantation, including the liver, leads to modification of characteristics of patients receiving a liver transplant. It results in an increasing number of elderly patients with all concomitant diseases typical for this age, including diverticulosis. The relevance of concomitant diverticulosis is associated with the fact that the impact of diverticular disease on patients’ wellbeing and health care costs is significant. Due to its universality, diverticular disease has a leading position among the main causes of health spending for gastrointestinal diseases [6]. Furthermore, diverticulosis has been shown to have a negative impact on health-related quality of life (QOL), including emotional QOL and physical function QOL [7, 8]. It has to be mentioned that according to previous studies more than one third of patients experienced persistent symptoms 1 to 2 years after an episode of uncomplicated diverticulitis [9]. In our study we investigated the influence of such factors as body mass index (BMI), Child-Pugh (C-P) and MELD score, viral etiology, presence of alcoholic disease and especially detection of diverticulosis during colonoscopy, on short-term results of LT with an emphasis on duration of patients’ hospitalization.

Material and methods

This prospective study was performed on patients who were hospitalized in the Hepatology, Gastroenterology and Liver Transplantation (HEGITO) Unit, FD Roosevelt Faculty Hospital, Banska Bystrica, Slovakia. The study included 206 cirrhotic patients who were selected for LT, i.e. patients with irreversible liver disease that was expected to be fatal without transplantation. Cirrhosis in these patients was diagnosed based on an interview (history of chronic liver disease), physical examination (typical signs of cirrhosis: spider naevi, palm erythema, ascites, spleno- and/or hepatomegaly, nail abnormalities, jaundice), imaging (ultrasound, CT, MRI) or endoscopy (presence of signs of portal hypertension, i.e., gastropathy, esophageal/gastric varices) and abnormal laboratory findings.

We defined two subgroups with respect to alcohol related (95 patients) and non-alcohol related (111 patients) etiology of cirrhosis. For further analysis, we also extracted two subgroups with viral and non-viral etiology of liver disease. The diagnosis of chronic hepatitis B (CHB) was based on raised serum transaminases for at least 6 months, positivity for hepatitis B virus (HBV) surface antigen (HBsAg) and anti-HB core IgG antibodies. Chronic hepatitis C was established in case of the presence of anti-hepatitis C virus (HCV) antibodies together with HCV-RNA for more than 6 months.

All the subjects were divided according to C-P grades A, B and C and MELD score (≤ 14 and > 14). The C-P score consists of ascites, hepatic encephalopathy (HE), prothrombin time, total bilirubin and albumin. Each measure is scored 1-3 points, with 3 indicating the most severe derangement. The sum of these points assigns the patient to one of the groups: into C-P grades A (5-6 points), B (7-9 points), C (10-15 points). The MELD score reflects liver and renal function and is based on INR, total bilirubin, and creatinine.

To evaluate the presence of diverticulosis most of the patients underwent colonoscopy before the procedure of LT. To achieve the criteria of complete colonoscopy the bottom of cecum and proximal lip of the ileocecal valve had to be visualized, and it required good bowel preparation defined as at least 6 points on the Boston Bowel Preparation Scale (BBPS).

The statistical analysis was performed with STATISTICA 10.0 (StatSoft Polska Sp. z o.o., Cracow, Poland). The data were expressed as median (interquartile range (IQR)). The Shapiro-Wilk test was used to evaluate the distribution. The statistical significance of the difference in studied variables was tested using the Mann-Whitney U-test and ANOVA rank Kruskal-Wallis tests for independent groups. Fisher’s exact test was used to determine the differences in diverticulosis presence. Correlations were analyzed with the Spearman rank correlation coefficient. Statistical significance was defined as values of p < 0.05.

Results

Comparison between females and males selected for liver transplantation

Severity of liver cirrhosis based on C-P and MELD scores did not differ significantly between females and males (10.0 [8.00-11.0] vs. 9.00 [8.00-11.0], p = 0.55 and 16.0 [13.6-19.0] vs. 15.0 [13.0-18.0], p = 0.08, respectively). We also did not observe any significant differences with respect to age or duration of hospitalization (p = 0.30 and p = 0.36). Females presented significantly lower BMI in comparison to males (24.0 [21.5-27.5] vs. 27.0 [25.0-30.0] kg/m2, p < 0.001). Diverticulosis was observed less often among females (4.0%) than among males (9.9%), but the difference was not statistically significant [OR = 0.43 (95% CI: 0.11-1.61, p = 0.24)].

Comparison of liver transplant patients with and without diverticulosis

As mentioned above, in our study we also analyzed the presence of colonoscopy proven diverticulosis among subjects undergoing LT. Diverticulosis was detected among 13 patients, which represents 6.3% of all patients undergoing investigation. Patients with diverticulosis were significantly older (59.6 [51.1-63.3] vs. 52.9 [43.8-59.2] years, p = 0.03). None of the other analyzed parameters differed between these two subgroups.

Duration of hospitalization after liver transplantation

The main purpose of this study was to analyze factors that could have an impact on the period that patients had to spend in hospital after transplantation. The duration of hospitalization did not differ significantly between patients with and without diverticulosis (27.5 [21.0-33.5] vs. 24.0 [18.0-32.0] days, p = 0.28). Significantly longer hospitalization was observed only among patients in C-P class C in comparison to class B. It is reflected in the positive correlation between C-P score and days of hospitalization (r = 0.22, p = 0.002).

Comparison of liver transplant patients with respect to BMI

The patients were divided into two subgroups based on BMI (BMI < 30 kg/m2 and ≥ 30 kg/m2). There were no significant differences concerning C-P score, MELD score and days of hospitalization in the groups of patients with different BMI (p = 0.68, p = 0.08, and p = 0.31, respectively). Patients with obesity were older in comparison to non-obese patients (56.4 [52.0-62.7] vs. 52.1 [42.2-57.8] years, p = 0.002). Diverticulosis was found less often among obese patients (3.0% vs. 8.6%), but the difference was not statistically significant [OR = 0.33 (95% CI: 0.04-2.64, p = 0.46)].

Comparison of liver transplantation patients according to severity of cirrhosis based on Child-Pugh and MELD score

Data comparing patients with various C-P score are presented in Table 1. According to the C-P score patients were divided into 3 groups. No significant differences in age and BMI were found with respect to liver disease severity as assessed with the C-P score. When patients with different stages of liver dysfunction according to C-P score were compared, we observed significantly longer hospitalization in class C compared to class B (30.0 [20.0-44.0] vs. 22.0 [17.0-27.7] days, p < 0.001). Surprisingly, there was no such difference comparing class A and B (p = 0.17) as well as A and C (p = 0.45).

Table 1

Analyzed parameters according to the severity of cirrhosis, as assessed by the Child-Pugh score

ParameterChild-Pugh A (n = 17)Child-Pugh B (n = 87)Child-Pugh C (n = 102)Child-Pugh A vs. B pChild-Pugh B vs. C pChild-Pugh A vs. C p
Hospitalization duration (days)27.0 (16.7-39.0)22.0(17.0-27.7)30.0 (20.0-44.0)0.17< 0.0010.45
Age (years)52.1 (38.5-56.6)53.4 (44.0-60.5)51.6 (38.9-57.5)0.250.220.73
BMI (kg/m2)25.0 (22.7-28.7)25.0 (22.0-28.0)26.0 (24.0-28.0)0.900.460.57
MELD score (points)11.0 (7.54-12.4)15.0 (12.9-16.0)19.0 (16.9-22.7)< 0.001< 0.001< 0.001
Diverticulosis (%)13.33.47.80.28

The patients were also divided according to MELD score into two groups: MELD ≤ 14 and MELD > 14. There were no significant differences with respect to BMI in the groups of patients with different MELD scores (p = 0.13). Contrary to the C-P score, we did not observe any significant differences in duration of hospitalization between these two subgroups (p = 0.23). Surprisingly, patients with a higher MELD score were significantly younger (p = 0.01). There was no difference in diverticulosis frequency between patients with higher and lower MELD scores (5.8% vs. 7.1%) [OR = 0.84 (95% CI: 0.26-2.69, p = 0.76)]. For details see Table 2.

Table 2

Analyzed parameters according to the severity of cirrhosis, as assessed by MELD score

ParameterMELD ≤ 14 (n = 70)MELD > 14 (n = 136)p
Hospitalization duration (days)23.5 (17.0-30.0)25.0 (19.0-33.0)0.23
Age (years)56.1 (47.3-61.6)52.3 (41.9-57.5)0.01
BMI (kg/m2)27.0 (23.0-29.5)26.0 (23.0-28.0)0.13
Child-Pugh score (points)8.0 (6.75-9.0)10.0 (9.0-11.0)< 0.001
Diverticulosis (%)7.15.80.76

Comparison of liver transplant patients with viral and non-viral etiology of cirrhosis

In our study, we differentiated the study group according to the etiology of cirrhosis into two subgroups: viral etiology (HBV or HCV) and non-viral etiology. None of the analyzed parameters differed significantly when these two subgroups were compared (Table 3).

Table 3

Analyzed parameters among patients with disease of viral and non-viral etiology

ParameterViralNon-viralp
Hospitalization duration (days)24.5 (18.5-27.5)24.0 (18.0-34.0)0.56
Age (years)54.5 (45.6-57.3)52.1 (42.2-59.3)0.63
BMI (kg/m2)26.0 (24.0-28.0)26.0 (22.0-28.0)0.46
Child-Pugh score (points)9.0 (7.5-11.0)9.0 (8.0-11.0)0.63
MELD score (points)14.0 (10.0-17.1)15.6 (13.0-18.3)0.07

Comparison of liver transplant patients with and without history of alcoholic liver disease

For further analysis patients were divided into two subgroups: 1) with history of alcoholic liver disease (ALD), which included 95 patients, and 2) without ALD – 111 patients. ALD patients were significantly older (p < 0.001) and had significantly higher BMI in comparison to non-ALD patients. Moreover, patients with ALD also had significantly higher C-P (p = 0.006) but not MELD score (p = 0.50). Surprisingly, proven overuse of alcohol in the past did not have an impact on duration of hospital stay. There was no significant difference between ALD and non-ALD patients regarding number of days that patients had to stay in hospital after LT. Diverticulosis was discovered more often among ALD patients (10.5%) than among non-ALD patients (2.7%). Documented alcohol abuse in the past was associated with a greater risk of diverticulosis [OR = 3.89 (95% CI: 1.13-15.87), p = 0.04]. For details see Table 4.

Table 4

Analyzed parameters among patients with and without history of alcoholic liver disease (ALD)

ParameterALD (n = 95)Non-ALD (n = 111)p
Hospitalization duration (days)23.5 (18.0-31.5)25.5 (18.0-33.0)0.38
Age (years)55.8 (50.8-59.8)50.1 (37.7-57.8)< 0.001
BMI (kg/m2)27.0 (24.0-30.0)25.0 (22.0-28.0)< 0.001
Child-Pugh score (points)10.0 (9.0-11.0)9.0 (7.0-11.0)0.006
MELD score (points)15.9 (14.0-18.6)15.2 (13.0-18.1)0.50
Diverticulosis (%)10.52.70.04

Correlations between analyzed parameters

In our study, we also scrutinized correlations between analyzed parameters (such as age of patients, BMI, C-P as well as MELD score) with an emphasis on the relationship between them and the duration of hospitalization. Only C-P score was positively associated with days of hospital stay (r = 0.22, p = 0.002), whereas MELD score was negatively associated with BMI (r = –0.15, p = 0.04) and age of LT patients (r = –0.20, p = 0.004), but it was not correlated with duration of hospitalization (p = 0.24).

Discussion

The development in the field of solid organ transplantation, and subsequently increasing importance of LT as a desirable therapy of chronic liver diseases, leads to modification of characteristics of patients receiving a liver transplant. As a result, various co-morbidities pose new challenges for clinicians to deal with. To the best of our knowledge, this is the first study to assess the influence of concomitant diverticulosis on short-term results of LT with an emphasis on duration of patients’ hospitalization.

Initially, at the stage of research planning we had proposed that concomitant diverticulosis would have resulted in posttransplant complications and consequently would have prolonged the time of hospitalization. However, presence of diverticulosis did not influence treatment duration and was not associated with longer hospital stay.

Analyzing previous publications, there are a few similar studies investigating the presence of diverticular disease and its complications after lung, heart, or kidney transplantation [1012]. Olson et al. [13] conducted a retrospective study to review patients undergoing lung transplant between 2007 and 2016 with posttransplant acute colonic diverticulitis. The study group consisted of 512 transplant recipients. According to Olson’s research the incidence of posttransplant diverticulitis (3.3%) was much higher than that reported in the general population (0.7%). Over 60% of diverticulitis cases occur within 2 years after transplantation, which is consistent with previous studies [14, 15]. Higher BMI at the time of listing for transplant was identified as a risk factor for diverticulitis after transplantation and the likelihood of developing recurrent diverticulitis.

What is interesting is that Olson’s study showed that patients with pretransplant diverticulosis experienced earlier posttransplant diverticulitis episodes, increased recurrence, and higher incidence of surgical intervention than patients without pretransplant diverticulosis. That fact illustrates the value of pretransplant colonoscopy. There is another crucial issue that needs to be mentioned in reference to diverticulosis and its complications among patients after solid organ transplantation. The classic presentation of diverticulitis may be complicated by immunosuppressive medications or the patient’s critical condition, which may delay diagnosis and intervention [13]. Glucocorticoids reduce infection defense capabilities by the inhibition of granulocytes and macrophages. In addition, steroids inhibit the action of certain pyrogenic interleukins and pain-inducing prostaglandins [16]. As a result, symptoms and classic signs of acute abdomen are masked under immunosuppression, and this leads to a diagnostic challenge.

Liver cirrhosis is a chronic disease that affects and unhinges homeostasis of other organs and systems in the human body, especially the gastrointestinal tract. A well-known phenomenon associated with cirrhosis is bacterial translocation (BT). BT or microbial translocation is defined as the migration of microorganisms or their products from the intestinal lumen into the mesenteric lymph nodes (MLN) and other tissue and organs [17]. The most evidenced clinical expression of pathological BT is spontaneous bacterial peritonitis (SBP) or bacteremia [18]. The etiology of intestinal barrier dysfunction in liver cirrhosis, resulting in BT, is probably multifactorial. Several studies have reported that the gut microbiota is changed in patients with liver cirrhosis, which is called dysbiosis. A quantitative alteration in Bacteroides/Firmicutes ratio, with an increase in potentially pathogenic bacteria including Enterobacteriaceae together with a reduction in specific autochthonous commensals, was observed [19, 20]. Gut dysbiosis seems to participate in the disruption of intestinal epithelial tight junctions and the imbalance of proliferation and apoptosis of intestinal epithelial cells [21]. The gut epithelium plays an important role in immune homeostasis as the first barrier that prevents BT. The intestinal barrier is constituted mainly by intestinal epithelial cells and their mucinous components [22]. The gut barrier is a complex dynamic structure made of mechanical (mucus layer, epithelial cells and endothelial cells), immunological (secretory IgA, lymphatic tissue, intestinal microbiota), functional (gut motility, gastric acid secretion, bile acids) and microbiological components involved in the selective regulation of intestinal permeability [23]. According to previous publications, the rate and degree of pathological BT increase with severity of liver disease. Pathological translocation of vital bacteria to MLN is a phenomenon of the decompensated stage. Direct data on culturable BT to MLN revealed a significantly higher rate in C-P C cirrhotic patients (30%) as compared to C-P B or A (8% and 3%, respectively) patients and C-P score was the only independent predictor for pathological BT [24, 25].

A study performed by Yeh et al. [26] investigated the clinical significance of BT after cirrhotic liver resection. In this study, bacterial cultures of MLNs before and after liver resection were performed in 181 cirrhotic patients. According to them, the incidence of BT after liver resection was significantly higher than before liver resection (19.9% vs. 0%, p < 0.001). Postoperative complications occurred in 17 patients (47.2%) in the BT group and 23 patients (15.9%) in the non-BT group (p < 0.001). BT group patients had a significantly higher infectious complication rate (44.4% vs. 7.6%, p < 0.001). In consequence, the postoperative hospital stay was significantly longer in the BT group (16.3 ±1.6 vs. 11.7 ±0.59 days, p = 0.01).

As we can easily notice, liver cirrhosis, per se, increases the risk of BT and consequently LT complications. Diverticulosis also predisposes to diminution of the gut barrier, leading to leaky gut. The diverticular fundus is frequently distended and thin walled. Due to the weakened resistance, microperforation can easily take place, in particular at the diverticular fundus, allowing inflammatory spread into pericolic tissues and abscess formation [27]. Additionally, stasis of fecal material within diverticula can be favored by a prolonged colonic transit, which in turn predisposes to altered microflora and bacterial overgrowth. All of these provoke an inflammatory reaction by means of cytokine release [28]. Previous publications described possible activation of Toll-like receptors (TLR) with a subsequent inflammatory reaction at the level of the perivisceral tissues [29, 30].

In our study we also analyzed the impact of alcohol intake on diverticulosis and duration of hospitalization among patients undergoing LT. Previous reports on the association of alcohol use and diverticular disease have been conflicting. Alcohol has multiple effects on the gastrointestinal tract. It can cause mucosal injury, impair motility, and inhibit the absorption of nutrients, resulting in various gastrointestinal disorders [31, 32]. Reduced rectosigmoid motility caused by alcohol consumption may be an important pathogenic factor of diverticula formation. Alcohol inhibits colonic motility through activation of the nuclear factor-κB pathway and the subsequent upregulation of inducible nitric oxide synthase expression, thus resulting in increased intracolonic pressure and colonic diverticulosis [33]. Some studies have also analyzed the influence of alcohol overuse on the probability of diverticular complications such as diverticular bleeding. The study of Nagata et al. [34] including 911 patients with diverticulosis presented increased odds of bleeding in moderate drinkers compared to non-drinkers. According to this information we could suppose that ALD patients were predisposed to some of the complications of diverticulosis. Surprisingly, proven overuse of alcohol in the past did not have any influence on duration of hospital stay. On the other hand, similarly to previous studies, diverticulosis was discovered more often among ALD patients (10.5%) than among non-ALD patients (2.7%).

We also differentiated the study group according to the etiology of cirrhosis into two subgroups, viral etiology (HBV or HCV) and non-viral etiology, although none of the analyzed parameters differed significantly when these two subgroups were compared. This seems to be consistent with the lack of any pathophysiological connection between hepatotropic virus infections and diverticulosis in the literature.

Taking into consideration the above data, it is clear that LT among cirrhotic patients with concomitant diverticulosis is fraught with higher risk of infectious complications that may prolong postoperative hospital stay, increase hospital costs, and even cause death. Surprisingly, according to our results there were no significant differences in duration of hospitalization of patients with and without diverticulosis. Despite the fact that we did not prove this correlation, diverticulosis still remains a challenging issue – mostly due to the persistent symptoms of diverticular disease that eventually have a negative impact on health-related QOL.

Unfortunately, our study has several limitations. First of all, the study group consisted of a relatively small number of patients, although this is related to the fact that the primary criterion of inclusion of patients in the study was LT but not presence of diverticular disease. Secondly, the follow-up of the study group comprised a short period after LT. According to previous publications diverticulosis complications mostly occur within 2 years of transplant. In consequence, some of them could have been missed in our study. The lack of analysis of such short-term LT complication as liver decompensation, bleeding, infection, and post-transplant mortality is another important limitation of our investigation. Thirdly, a more perspicacious assessment of the potential influence of diverticulosis among LT patients was hampered by the lack of data on detailed complications such as diverticulitis or diverticular bleeding.

Conclusions

In conclusion, our study revealed, for the first time, that the presence of colonoscopy proved diverticulosis among subjects undergoing LT did not influence the duration of hospitalization after the procedure. Significantly longer hospitalization was observed only among patients in C-P class C in comparison to class B, and it was reflected in a positive correlation between C-P score and days of hospitalization. Contrarily, MELD score seemed not to be an accurate instrument to predict recovery. The fact that patients with proven ALD had greater risk of diverticulosis (OR = 3.89) indicates to us that this group of patients requiers particular colonoscopic surveillance. According to our findings, it is difficult to evaluate the value of routine pretransplant colonoscopy, due to the fact that our study was limited by a short-term follow-up. However, based on the previous publications referring to complications of diverticular disease after transplantations of other solid organs, we could suppose that pretransplant colonoscopy might decrease the risk of serious diverticulitis or even colon perforation. The aforementioned studies highlighted the fact that the rate of diverticulitis in transplant or immunosuppressed patients is higher than in the general population, and its clinical course in such patients may be more severe. Simultaneously, abdominal signs are often subtle, which may delay diagnosis and intervention. Considering all the results, to determine the exact impact of diverticulosis on short-term results of LT, additional studies are required.

Disclosure

The authors declare no conflict of interest.

References

1 

Samuel D, Coilly A. Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation. BMC Med 2018; 16: 113.

2 

European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol 2016; 64: 433-485.

3 

Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871.

4 

Stollman N, Raskin JB. Diverticular disease of the colon. Lancet 2004; 363: 631-639.

5 

Peery AF, Sandler RS. Diverticular disease: reconsidering conventional wisdom. Clin Gastroenterol Hepatol 2013; 11: 1532-1537.

6 

Papa A, Papa V. The economic burden of diverticular disease. J Clin Gastroenterol 2016; 50 Suppl 1: S2-3.

7 

Justin V, Uranues S, Rabl H, et al. Quality of life in uncomplicated recurrent diverticulitis: surgical vs. conservative treatment. Sci Rep 2020; 10: 10261.

8 

Tursi A, Franceschi M, Elisei W, et al. The natural history of symptomatic uncomplicated diverticular disease: a long-term follow-up study. Ann Gastroenterol 2021; 34: 208-213.

9 

van Dijk ST, Daniels L, de Korte N, et al. Quality of life and persistent symptoms after uncomplicated acute diverticulitis. Dis Colon Rectum 2019; 62: 608-614.

10 

Oor JE, Atema JJ, Boermeester MA, et al. A systematic review of complicated diverticulitis in post-transplant patients. J Gastrointest Surg 2014; 18: 2038-2046.

11 

Domínguez Fernández E, Albrecht KH, Heemann U, et al. Prevalence of diverticulosis and incidence of bowel perforation after kidney transplantation in patients with polycystic kidney disease. Transpl Int 1998; 11: 28-31.

12 

Scotti A, Santangelo M, Federico S, et al. Complicated diverticulitis in kidney transplanted patients: analysis of 717 cases. Transplant Proc 2014; 46: 2247-2250.

13 

Olson MT, Elnahas S, Dameworth J, et al. Management and outcomes of diverticulitis after lung transplantation. Prog Transplant 2020; 30: 235-242.

14 

Larson ES, Khalil HA, Lin AY, et al. Diverticulitis occurs early after lung transplantation. J Surg Res 2014; 190: 667-671.

15 

Miller CB, Malaisrie SC, Patel J, et al. Intraabdominal complications after lung transplantation. J Am Coll Surg 2006; 203: 653-660.

16 

Floman Y, Zor U. Mechanism of steroid action in inflammation: inhibition of prostaglandin synthesis and release. Prostaglandins 1976; 12: 403-413.

17 

Fukui H. Leaky gut and gut-liver axis in liver cirrhosis: Clinical studies update. Gut Liver 2021; 15: 666-676.

18 

Bellot P, Francés R, Such J. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications. Liver Int 2013; 33: 31-39.

19 

Fukui H. Role of gut dysbiosis in liver diseases: what have we learned so far? Diseases 2019; 7: 58.

20 

Giannelli V, Di Gregorio V, Iebba V, et al. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis. World J Gastroenterol 2014; 20: 16795-16810.

21 

Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology 2014; 146: 1513-1524.

22 

Seo YS, Shah VH. The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension. Clin Mol Hepatol 2012; 18: 337-346.

23 

Ponziani FR, Zocco MA, Cerrito L, et al. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications. Expert Rev Gastroenterol Hepatol 2018; 12: 641-656.

24 

Cirera I, Bauer TM, Navasa M, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001; 34: 32-37.

25 

Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol 2014; 60: 197-209.

26 

Yeh DC, Wu CC, Ho WM, et al. Bacterial translocation after cirrhotic liver resection: a clinical investigation of 181 patients. J Surg Res 2003; 111: 209-214.

27 

Wedel T, Barrenschee M, Lange C, et al. Morphologic basis for developing diverticular disease, diverticulitis, and diverticular bleeding. Viszeralmedizin 2015; 31: 76-82.

28 

Severi C, Carabotti M, Cicenia A, et al. Recent advances in understanding and managing diverticulitis. F1000Res 2018; 7: F1000 Faculty Rev-971.

29 

Foligne B, Nutten S, Grangette C, et al. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol 2007; 13: 236-243.

30 

Piccioni A, Franza L, Brigida M, et al. Gut microbiota and acute diverticulitis: Role of probiotics in management of this delicate pathophysiological balance. J Pers Med 2021; 11: 298.

31 

Bujanda L. The effects of alcohol consumption upon the gastrointestinal tract. Am J Gastroenterol 2000; 95: 3374-3382.

32 

Stermer E. Alcohol consumption and the gastrointestinal tract. Isr Med Assoc J 2002; 4: 200-202.

33 

Yan Y, Wu JS, Pan S. Age, alcohol, sex, and metabolic factors as risk factors for colonic diverticulosis. World J Clin Cases 2022; 10: 136-142.

34 

Nagata N, Niikura R, Aoki T, et al. Colonic diverticular hemorrhage associated with the use of nonsteroidal anti-inflammatory drugs, low-dose aspirin, antiplatelet drugs, and dual therapy. J Gastroenterol Hepatol 2014; 29: 1786-1793.

Copyright: © Clinical and Experimental Hepatology. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.